| [1] |
黎尚荣，沈宁，黑子清，等．肝移植术后患者急性肺损伤及其早期危险因素分析[J]．中华医学杂志，2008, 88(43):3049-3052.
|
| [2] |
Villar J, Blanco J, del Campo R, et al. Assessment of PaO2/FiO2 for stratification of patients with moderate and severe acute respiratory distress syndrome[J]. BMJ Open, 2015, 5(3):e006812.
|
| [3] |
Madotto F, Pham T, Bellani G, et al. Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study[J]. Intensive Care Med, 2018, 44(5):564-577.
|
| [4] |
Bellani G, Laffey JG, Pham T, et al. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries[J]. JAMA, 2016, 315(8):788-800.
|
| [5] |
Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition[J]. JAMA, 2012, 307(23):2526-2533.
|
| [6] |
McAuley DF, Laffey JG, O'Kane CM, et al. Simvastatin in the acute respiratory distress syndrome[J]. N Engl J Med, 2014, 371(18):1695-1703.
|
| [7] |
Perkins GD, Gates S, Park D, et al. The beta agonist lung injury trial prevention. a randomized controlled trial[J]. Am J Respir Crit Care Med, 2014, 189(6):674-683.
|
| [8] |
Laffey JG, Matthay MA. Fifty years of research in ARDS. cell-based therapy for acute respiratory distress syndrome. biology and potential therapeutic value[J]. Am J Respir Crit Care Med, 2017, 196(3):266-273.
|
| [9] |
Hayes M, Masterson C, Devaney J, et al. Therapeutic efficacy of human mesenchymal stromal cells in the repair of established ventilator-induced lung injury in the rat[J]. Anesthesiology, 2015, 122(2):363-373.
|
| [10] |
Lee JW, Fang X, Gupta N, et al. Allogeneic human mesenchymal stem cells for treatment of E. coli endotoxin-induced acute lung injury in the ex vivo perfused human lung[J]. Proc Natl Acad Sci U S A, 2009, 106(38): 16357-16362.
|
| [11] |
Wilson JG, Liu KD, Zhuo H, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: a phase 1 clinical trial[J]. Lancet Respir Med, 2015, 3(1):24-32.
|
| [12] |
Zheng G, Huang L, Tong H, et al. Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study[J]. Respir Res, 2014, 15(1):39.
|
| [13] |
Oba Y, Salzman GA. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury[J]. N Engl J Med, 2000, 343(11):813-814.
|
| [14] |
Grissom CK, Hirshberg EL, Dickerson JB, et al. Fluid management with a simplified conservative protocol for the acute respiratory distress syndrome[J]. Crit Care Med, 2015, 43(2):288-295.
|
| [15] |
Liu G, Lv H, An Y, et al. Tracking of transplanted human umbilical cord-derived mesenchymal stem cells labeled with fluorescent probe in a mouse model of acute lung injury[J]. Int J Mol Med, 2018, 41(5):2527-2534.
|
| [16] |
Murray JF, Matthay MA, Luce JM, et al. An expanded definition of the adult respiratory distress syndrome[J]. Am Rev Respir Dis, 1988, 138(3):720-723.
|
| [17] |
Warren MA, Zhao Z, Koyama T, et al. Severity scoring of lung oedema on the chest radiograph is associated with clinical outcomes in ARDS[J]. Thorax, 2018, 73(9):840-846.
|
| [18] |
Islam MN, Das SR, Emin MT, et al. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury[J]. Nat Med, 2012, 18(5):759-765.
|
| [19] |
Kor DJ, Gong MN, Levy BD. Aspirin and acute respiratory distress syndrome-reply[J]. JAMA, 2016, 316(12):1318.
|
| [20] |
Michael JR, Barton RG, Saffle JR, et al. Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS[J]. Am J Respir Crit Care Med, 1998, 157(5 Pt 1):1372-1380.
|
| [21] |
Shyamsundar M, McAuley DF, Ingram RJ, et al. Keratinocyte growth factor promotes epithelial survival and resolution in a human model of lung injury[J]. Am J Respir Crit Care Med, 2014, 189(12): 1520-1529.
|
| [22] |
Matthay MA, Calfee CS, Zhuo H, et al. Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial[J]. Lancet Respir Med, 2019, 7(2):154-162.
|
| [23] |
Mouloudi E, Massa E, Papadopoulos S, et al. Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae among intensive care unit patients after orthotopic liver transplantation: risk factors for infection and impact of resistance on outcomes[J]. Transplant Proc, 2014, 46(9):3216-3218.
|
| [24] |
Song SH, Li XX, Wan QQ, et al. Risk factors for mortality in liver transplant recipients with ESKAPE infection[J]. Transplant Proc, 2014, 46(10):3560-3563.
|